Cognitive Impairment Associated with Atorvastatin and Simvastatin

Pharmacotherapy

Volumn 23, Issue 12 I, 2003, Pages 1663-1667

  King, Deborah S ^a,b,c   Wilburn, Amanda J ^b   Wofford, Marion R ^a   Harrell, T Kristopher ^b   Lindley, Brent J ^b   Jones, Daniel W ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Atorvastatin; Cognitive impairment; Simvastatin; Statins

Indexed keywords

ATORVASTATIN; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE; LISINOPRIL; METOPROLOL; SIMVASTATIN;

ABDOMINAL PAIN; AGED; ALZHEIMER DISEASE; ARTHRALGIA; ARTICLE; CASE REPORT; COGNITIVE DEFECT; CONSTIPATION; DEMENTIA; DIARRHEA; FEMALE; HEADACHE; HEPATITIS; HUMAN; HYPERLIPIDEMIA; INFLUENZA; LIVER FAILURE; MUSCLE CRAMP; MYALGIA; MYOPATHY; NAUSEA; PRACTICE GUIDELINE; RASH; RHABDOMYOLYSIS;

AGED; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEMORY DISORDERS; PYRROLES; SIMVASTATIN;

EID: 0344011137     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.15.1663.31953     Document Type: Article

References (26)

1. Orsi A, Sherman O, Woldeselassie Z. Simvastatin-associated memory loss. Pharmacotherapy 2001;21:767-9.
2. Anonymous. Top 200 drug list. Available from http://www rxlist/top200htm. Accessed January 8, 2003.
3. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999;20:1969-73.
4. Sacks FM, Pfeiffer MA, Moye LA, et al, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
5. Borghi C, Veronesi M, Prandin MG, Dormi A, Ambrosioni E. Statins and blood pressure regulation. Curr Hypertens Rep 2001;3:281-8.
6. Tonolo G, Melis MG, Formato M, et al. Additive effects of simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. Eur J Clin Invest 2000;30:980-7.
7. Chan KA, Andrade SE, Boles M, et al. Inhibitors of HMG-CoA reductase and risk of fracture among older women. Lancet 2000;355:2185-8.
8. Edwards CJ, Hart DJ, Sector TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 2000;355:2218-19.
9. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-9.
10. Sugiyama M, Kodama T, Konishi K, Abe K, Asami S, Oikawa S. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 2000;271:688-92.
11. Paolisso G, Barbagallo M, Petrella G, et al. Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic noninsulin dependent diabetic patients. Atherosclerosis 2000;150:121-7.
12. Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Arch Int Med 2001;161:1405-10.
13. Scott HD, Laake K. Statins for the prevention of Alzheimer's disease (Cochrane review) [abstr]. Cochrane Database Syst Rev 2001;4:CD003160.
14. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegal G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-43.
15. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356:1627-31.
16. Simons M, Keller P, Dichgans J, Schulz JB. Cholesterol and Alzheimer's disease: is there a link? Neurology 2001;57:1089-93.
17. Merck & Co. Zocor (simvastatin) package insert. Whitehouse Station, NJ; June 2001
18. Parke Davis. Lipitor (atorvastatin) package insert. Morris Plains, NJ; 2000.
19. Merck & Co. Mevacor (lovastatin) package insert. Whitehouse Station, NJ; September 2000.
20. Novartis. Lescol (fluvastatin) package insert. East Hanover, NJ; January 2001.
21. Bristol-Myers Squibb Pharmaceutical. Pravachol (pravastatin) package insert. Princeton, NJ; May 1999.
22. Kostis JB, Rosen RC, Wilson AC. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia. J Clin Pharmacol 1994;34:989-96.
23. Rockwood K, Kirkland S, Hogan DB, et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002;59:223-7.
24. Kehoe WA. Statins and memory. Pharmacists letter March 2002. Available from http://www.pharmacistsletter.com. Accessed March 8, 2002.
25. Muldoon MF, Barger SD, Ryan CM, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000;108:538-47.
26. Stewart RA, Sharples KJ, North FM, Menkes DB, Baker J, Simes J. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin: the lipid study investigators. Arch Intern Med 2000;160:3144-52.